Insmed
INSM
378 hedge funds and large institutions have $11.7B invested in Insmed in 2024 Q2 according to their latest regulatory filings, with 130 funds opening new positions, 132 increasing their positions, 100 reducing their positions, and 37 closing their positions.
350% more funds holding in top 10
Funds holding in top 10: 6 → 27 (+21)
251% more first-time investments, than exits
New positions opened: 130 | Existing positions closed: 37
189% more capital invested
Capital invested by funds: $4.07B → $11.7B (+$7.67B)
32% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 100
31% more funds holding
Funds holding: 288 → 378 (+90)
7.71% more ownership
Funds ownership: 100.99% → 108.7% (+7.7%)
2% less call options, than puts
Call options by funds: $458M | Put options by funds: $469M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$165M |
| 2 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$137M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$125M |
| 4 |
JP Morgan Chase
New York
|
+$102M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$96.6M |
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$108M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$88.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.1M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$53.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$48.2M |
INSM Hedge Fund Activity: Q2 2024 in Review
378 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q2 2024, worth a combined $11.7B — up 189% from $4.07B a quarter earlier.
Buyers outnumbered sellers: 130 funds opened new INSM positions and 37 closed out — a net gain of 93 holders — while 132 added to existing stakes and 100 trimmed.
The largest buyer was Capital International Investors, adding an estimated $165M. The largest seller was Deep Track Capital, cutting an estimated $108M.
- 378 institutional investors held Insmed (INSM) as of Q2 2024, up from 288 in Q1 2024.
- Funds reported $11.7B of Insmed stock for Q2 2024, up 189% quarter-over-quarter.
- 130 funds opened new Insmed positions in Q2 2024 and 37 closed out, a net change of +93 holders.
- The largest Insmed buyer in Q2 2024 was Capital International Investors, an estimated $165M added.
- The largest Insmed seller in Q2 2024 was Deep Track Capital, an estimated $108M sold.
Based on aggregated 13F filings for Q2 2024.